Infusystem Holdings Inc (INFU) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Infusystem Holdings Inc  (NYSEAMER: INFU)
 

Infusystem Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Infusystem Holdings Inc's inventory turnover ratio, the ratio that measures Infusystem Holdings Inc's ability to manage its supply chain, sequentially decreased to 10.92 in the second quarter 2026, but it does not raise any concerns as Infusystem Holdings Inc continue to execute well, and the inventory turnover ratio remains above the average. Average processing period, for Infusystem Holdings Inc's inventories remained unchanged at 33 days, in the Jun 30 2026 quarter.

Within Healthcare sector 28 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 309 in the first quarter 2026, to 359.

INFU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Infusystem Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INFU Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -2.63 % -4.32 % -17.42 % -16.57 % -17.12 %
Y / Y Cost of Sales Growth -3.77 % -9.95 % 1.04 % -3.73 % -5.3 %
Inventory Turnover Ratio (TTM) 10.92 10.96 11.1 10.55 10.18
INFU's Total Ranking # 359 # 309 # 272 # 221 # 298
Average inventory processing period 33 33 33 35 36
Seq. Inventory Growth -5.37 % 8.18 % -3.56 % -1.38 % -7.01 %
Seq. Cost of Sales Growth 10.84 % -11.35 % 0.81 % -2.85 % 3.72 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 11
Healthcare Sector # 29
Overall Market # 359

Inventory Turnover Ratio Statistics
High Average Low
12.68 9.22 1.82
(Sep 30 2018)   (Sep 30 2012)



INFU Company Profile >> Back to INFU Efficiency Comparisons >> Compare INFU Inventory Turnover Ratio to its Competitors

Financial Statements
Infusystem Holdings Inc's Inventories $ 6 Millions Visit INFU's Balance sheet
Infusystem Holdings Inc's Cost of Revenues TTM $ 61 Millions Visit INFU's Income Statement
What are INFU's Sales? Visit INFU's Sales by Segment

Other Inventory Turnover Ratios
Infusystem Holdings Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
INFU's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for INFU's Competitors
Inventory Turnover Ratio for INFU's Suppliers
Inventory Turnover Ratio for INFU's Customers

You may also want to know
INFU's Sales Growth Rates INFU's Pe Price to earnings ratio INFU's Receivables Turnover Ratio INFU's Stock Quote
INFU's Net Income Growth Rates INFU's Ps Price to Sales ratio INFU's Sales per Employee INFU's Asset Turnover Ratio
INFU's Net Margin INFU's Pb Price to Book ratio INFU's Financial Strength Ratios INFU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Prophase Labs Inc   26.86 $ 3.196  Millions$ 0  Millions
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Viemed Healthcare Inc   24.71 $ 128.283  Millions$ 5  Millions
Teladoc Health Inc   22.32 $ 772.590  Millions$ 35  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Adapthealth Corp   20.25 $ 2,676.899  Millions$ 132  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Aspira Women s Health inc   19.13 $ 5.073  Millions$ 0  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Edap Tms Sa  9.67 $ 62.351  Millions$ 6  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions

Date modified: 2026-09-26T06:50:52+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.